Suven Pharmaceuticals Limited (SUVENPHAR.NS)
INR 1149.6
(8.59%)
INR 1149.6
(8.59%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 4.6 Billion INR | -32.3% |
| 2022 | 5.18 Billion INR | -4.21% |
| 2021 | 5.41 Billion INR | 32.14% |
| 2020 | 4.09 Billion INR | 14.37% |
| 2019 | 3.58 Billion INR | -8.25% |
| 2018 | 3.9 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 665.3 Million INR | 68.26% |
| 2023 Q4 | 560.97 Million INR | -15.94% |
| 2023 Q3 | 667.37 Million INR | -36.99% |
| 2023 Q1 | 1.54 Billion INR | -8.36% |
| 2023 Q2 | 1.05 Billion INR | -31.42% |
| 2023 FY | 3.51 Billion INR | -32.3% |
| 2022 Q1 | 1.39 Billion INR | -5.76% |
| 2022 Q4 | 1.68 Billion INR | 14.28% |
| 2022 Q3 | 1.47 Billion INR | 49.31% |
| 2022 Q2 | 987.68 Million INR | -29.14% |
| 2022 FY | 5.18 Billion INR | -4.21% |
| 2021 Q1 | 1.05 Billion INR | 22.85% |
| 2021 Q2 | 1.12 Billion INR | 6.61% |
| 2021 Q4 | 1.47 Billion INR | -15.73% |
| 2021 Q3 | 1.75 Billion INR | 55.88% |
| 2021 FY | 5.41 Billion INR | 32.14% |
| 2020 Q3 | 1.29 Billion INR | 42.2% |
| 2020 FY | 4.09 Billion INR | 14.37% |
| 2020 Q2 | 909.89 Million INR | -13.36% |
| 2020 Q1 | 1.05 Billion INR | 49.05% |
| 2020 Q4 | 859.7 Million INR | -33.56% |
| 2019 Q3 | 740.46 Million INR | -38.27% |
| 2019 Q4 | 704.58 Million INR | -4.85% |
| 2019 FY | 3.58 Billion INR | -8.25% |
| 2019 Q2 | 1.19 Billion INR | 23.71% |
| 2019 Q1 | 969.6 Million INR | -18.51% |
| 2018 Q3 | 440 Million INR | 0.0% |
| 2018 Q4 | 1.18 Billion INR | 170.41% |
| 2018 FY | 3.9 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 19.98% |
| Hester Biosciences Limited | 364.77 Million INR | -1163.164% |
| Aarti Drugs Limited | 7.14 Billion INR | 35.546% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -47.298% |
| Albert David Limited | 1.33 Billion INR | -245.282% |
| Alembic Limited | 767.77 Million INR | -500.133% |
| Alkem Laboratories Limited | 19.46 Billion INR | 76.325% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -1838.746% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -22206.56% |
| Brooks Laboratories Limited | -72.25 Million INR | 6477.184% |
| Eris Lifesciences Limited | 5.18 Billion INR | 11.079% |
| FDC Limited | 3.03 Billion INR | -51.88% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 48.685% |
| Gufic Biosciences Limited | 2.89 Billion INR | -59.224% |
| Hikal Limited | 1.49 Billion INR | -208.369% |
| Ind-Swift Limited | 1.22 Billion INR | -275.838% |
| Innova Captab Limited | 2.53 Billion INR | -81.875% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 6.769% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -2052.702% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 11.204% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -141.703% |
| Lupin Limited | 27.75 Billion INR | 83.401% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -16680.694% |
| Medico Remedies Limited | 277.11 Million INR | -1562.701% |
| Morepen Laboratories Limited | 4.17 Billion INR | -10.394% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -18.43% |
| Orchid Pharma Limited | 2.36 Billion INR | -95.15% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -65.386% |
| RPG Life Sciences Limited | 2.29 Billion INR | -101.005% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -2114.681% |
| Sigachi Industries Limited | 1.47 Billion INR | -212.617% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 219.589% |
| Themis Medicare Limited | 1.3 Billion INR | -253.59% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Vaishali Pharma Limited | 6.29 Million INR | -73106.911% |
| Wanbury Limited | 1.7 Billion INR | -169.894% |
| Windlas Biotech Limited | 1.29 Billion INR | -254.737% |
| ZIM Laboratories Limited | 1.09 Billion INR | -319.596% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -129.346% |
| Ipca Laboratories Limited | 29.59 Billion INR | 84.432% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 95.582% |
| Venus Remedies Limited | 534.65 Million INR | -761.804% |
| Sakar Healthcare Limited | 495.5 Million INR | -829.886% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 95.591% |
| Divi's Laboratories Limited | 18.31 Billion INR | 74.835% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -2.989% |
| Mankind Pharma Limited | 40.86 Billion INR | 88.725% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Laurus Labs Limited | 3.94 Billion INR | -16.691% |
| Neuland Laboratories Limited | 5.31 Billion INR | 13.359% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 38.904% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 29.139% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 89.849% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -641.939% |
| Wockhardt Limited | 140 Million INR | -3191.174% |
| Bal Pharma Limited | 214.56 Million INR | -2047.395% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 93.197% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -274.301% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -735.34% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 36.229% |
| Shilpa Medicare Limited | 3.76 Billion INR | -22.492% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 19.67 Billion INR | 76.584% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -162666.733% |
| Granules India Limited | 6.52 Billion INR | 29.42% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -1748.596% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 81.813% |
| NATCO Pharma Limited | 25.96 Billion INR | 82.252% |
| Suven Life Sciences Limited | -1.22 Billion INR | 475.882% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | 11.829% |
| Indoco Remedies Limited | 1.52 Billion INR | -202.259% |
| Alpa Laboratories Limited | 61.51 Million INR | -7390.276% |
| Lasa Supergenerics Limited | -458 Million INR | 1106.025% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 211.971% |